Analyst
ED, Generics and Commercial
Equibles does not estimate personal net worth.
Soumya Chava is recorded as Analyst at ED, Generics and Commercial. Soumya Chava has spoken on 1 earnings call across 1 company, most recently for Laurus Labs Limited on April 30, 2026. The companies whose calls Soumya Chava spoke on are classified in the Healthcare sector.
“Revenue from the Affordable Medicines Division formally generated at 1,223 costs in Q4, with the momentum sustained on an absolute basis, though the growth has been slightly moderated.”
ED, Generics and Commercial
Analyst
Transcript header (unverified)
Laurus Labs Limited
Drug Manufacturers - Specialty & Generic · Healthcare
Earnings Call
Laurus Labs Limited
